Filter by

The many faces of Robin Hobbs

News / 6 November 2016

Robin has been at ARMI for around four years now and says that the things he enjoys most are the diverse range of research being conducted there and the dynamic and enthusiastic nature of the scientific environment, probably owing to the high number of junior group leaders, including himself.

More than a decade ago, scientists around the world confidently predicted that stem cell research would revolutionise medicine. Enabling legislation followed the technology, as did a dramatic increase in funding that paralleled the public’s impatient expectations. It’s only within the past couple of years that we have finally started to see the vanguard of this regenerative movement begin to be realised – what began as a trickle of clinical trials has now become a steady stream around the globe.

A Regenerative Medicine Advisory Group to be chaired by Silvio Tiziani has been formed by AusBiotech.

The Group, comprising 10 members, will provide advice on current and emerging issues and trends facing the regenerative medicine sector in Australia and overseas, improve and engage the sector, generate a clear definition of regenerative medicine and address key advocacy issues.